OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
Petrina Kamya, Ivan V. Ozerov, Frank W. Pun, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 10, pp. 3961-3969
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Integrating artificial intelligence in drug discovery and early drug development: a transformative approach
Alberto Ocaña, Atanasio Pandiella, Cristian Privat, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2

Advancements and applications of Artificial Intelligence in cardiology: Current trends and future prospects
David B. Olawade, Nicholas Aderinto, Gbolahan Olatunji, et al.
Journal of Medicine Surgery and Public Health (2024) Vol. 3, pp. 100109-100109
Open Access | Times Cited: 12

The Artificial Intelligence-Driven Pharmaceutical Industry: A Paradigm Shift in Drug Discovery, Formulation Development, Manufacturing, Quality Control, and Post-Market Surveillance
Kampanart Huanbutta, Kanokporn Burapapadh, Pakorn Kraisit, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 203, pp. 106938-106938
Open Access | Times Cited: 11

Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
Thomas Cyberski, Alka Singh, Michael Korzinkin, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5

Precious3GPT: Multimodal Multi-Species Multi-Omics Multi-Tissue Transformer for Aging Research and Drug Discovery
Fedor Galkin, Владимир Наумов, Stefan Pushkov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5

AlphaFold and what is next: bridging functional, systems and structural biology
Kacper Szczepski, Łukasz Jaremko
Expert Review of Proteomics (2025)
Closed Access

Advances in medical devices using nanomaterials and nanotechnology: Innovation and regulatory science
Chubing Lin, Xin Huang, Yueguang Xue, et al.
Bioactive Materials (2025) Vol. 48, pp. 353-369
Closed Access

Large Model Era: Deep Learning in Osteoporosis Drug Discovery
Junlin Xu, Xiaobo Wen, Li Sun, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access

A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences
Priyanka Kandhare, Mrunal Kurlekar, Tanvi Deshpande, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 9-9
Open Access

Next-gen senotherapeutics: AI/ML-driven strategies for aging and age-related disorders
Prashanth S. Javali, Ashish Kumar, S. Sarkar, et al.
Advances in pharmacology (2025)
Closed Access

Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities
Wahiba Oualikene-Gonin, Marie‐Christine Jaulent, Jean-Pierre Thierry, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Navigating the frontier of drug-like chemical space with cutting-edge generative AI models
Antonio Lavecchia
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104133-104133
Open Access | Times Cited: 3

Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies
Bhupendra Raj Giri, Deeksha Jakka, Michael A. Sandoval, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1325-1325
Open Access | Times Cited: 3

Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 2

The Millennia-Long Development of Drugs Associated with the 80-Year-Old Artificial Intelligence Story: The Therapeutic Big Bang?
Aurore Crouzet, Nicolás López, Benjamin Riss Yaw, et al.
Molecules (2024) Vol. 29, Iss. 12, pp. 2716-2716
Open Access | Times Cited: 1

FORWARD: A Learning Framework for Logical Network Perturbations to Prioritize Targets for Drug Development
Saptarshi Sinha, Ella McLaren, Madhubanti Mullick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Key Aspects of Biosensing for Instant Screening Tests
Joydip Sengupta
Biosensors and Bioelectronics X (2024) Vol. 20, pp. 100529-100529
Open Access | Times Cited: 1

Accelerating drug discovery, development, and clinical trials by artificial intelligence
Yilun Zhang, Mohamed Mastouri, Yang Zhang
Med (2024) Vol. 5, Iss. 9, pp. 1050-1070
Closed Access | Times Cited: 1

Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis
Bonnie Hei Man Liu, Yuezhen Lin, Xi Long, et al.
Advanced Science (2024)
Open Access | Times Cited: 1

Clinical Advancement Forecasting
Eric Czech, Rafal Wojdyla, Daniel Himmelstein, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

AI for Health and Medicine
Qinghai Miao, Fei-Yue Wang
(2024), pp. 65-73
Closed Access

Page 1 - Next Page

Scroll to top